Cultural Heritage
Qizheng Tibetan Medicine Promotes “Tibetan Medicine External Therapies” Overseas
Release time:
2017-08-30 14:46
Recently, at the Harvard Forum on Traditional Chinese Medicine hosted by the Massachusetts Association of Chinese Medicine in the U.S., Qizheng Tibetan Medicine—a leading Tibetan medicine enterprise that has long collaborated with Harvard University on research into Tibetan medicine—introduced to over 100 local healthcare professionals China’s first batch of Intangible Cultural Heritage items: “Tibetan External Therapies.” The presentation was met with an enthusiastic response.
According to Chen Wei-wu, General Manager of the Qizheng Tibetan Medicine R&D Center and Director of the Institute for External Treatment of Traditional Tibetan Medicine, Tibetan external therapy is one of the four fundamental therapeutic approaches in Tibetan medicine. External therapy is employed when drug treatments fail to produce significant effects, when certain specific diseases require exclusively external treatment, or when both internal and external therapies need to be combined. The theoretical foundation of Tibetan external therapy throughout history has primarily been drawn from the "Four Medical Tantras," specifically its section on external treatments. There are five main types of external therapy: bloodletting, moxibustion, hot and cold compresses, medicinal baths, and topical applications—each of which relies on the unique medicinal substances and medical devices characteristic of Tibetan medicine.
The audience at the scene showed great interest in Tibetan medicine and eagerly requested samples to try after the session ended. Many attendees remarked that they had previously known very little about the traditional medicines of China’s ethnic minorities, but now realized that Tibetan medicine is an excellent complement to traditional Chinese medicine and an indispensable part of promoting Chinese culture.
It is understood that in 2013, Qizheng Tibetan Medicine collaborated with Professor David Christiani of Harvard University, an internationally renowned expert in occupational disease research, to establish the Harvard Tibetan Medicine Research Laboratory. The laboratory focuses on the role and expansion of Tibetan medicine in addressing major diseases from a global perspective, and explores the clinical value of classic Tibetan medicines within the framework of modern integrative medicine.
Liu Kaili, Vice President of the China Association for Ethnic Medicine and President of Qizheng Tibetan Medicine, stated that currently, the internationalization of Traditional Chinese Medicine (TCM) is primarily driven by traditional TCM practices such as acupuncture; the degree of internationalization of ethnic medicines, however, remains far from sufficient. As Qizheng Tibetan Medicine seeks to expand into the U.S. market, its first step is to promote the traditional culture of Tibetan medicine, break down cultural barriers, and enhance consumer awareness of Tibetan medicine.
Reporting media: Tibet Daily
Report link: http://epaper.chinatibetnews.com/xzrb/html/2017-08/30/content_786800.htm
Copyright Qizheng Tibetan Medicine Co., Ltd. All rights reserved. ICP Filing Number:
Internet drug information service qualification certificate number:（藏） Non-Commercial - 2018-0004 SEO